Traders bought shares of Johnson & Johnson (NYSE:JNJ) on weakness during trading on Wednesday. $230.72 million flowed into the stock on the tick-up and $78.79 million flowed out of the stock on the tick-down, for a money net flow of $151.93 million into the stock. Of all companies tracked, Johnson & Johnson had the 6th highest net in-flow for the day. Johnson & Johnson traded down ($0.13) for the day and closed at $119.34

A number of brokerages have recently commented on JNJ. BTIG Research reissued a “hold” rating on shares of Johnson & Johnson in a report on Sunday, May 22nd. Leerink Swann reissued a “buy” rating on shares of Johnson & Johnson in a report on Sunday, May 22nd. Zacks Investment Research raised Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 price target on the stock in a report on Friday, August 5th. Deutsche Bank AG reissued a “buy” rating on shares of Johnson & Johnson in a report on Thursday, May 19th. Finally, Jefferies Group reissued a “hold” rating and set a $109.00 price target (up from $108.00) on shares of Johnson & Johnson in a report on Tuesday, June 14th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have given a buy rating to the stock. Johnson & Johnson currently has an average rating of “Hold” and a consensus price target of $119.53.

The firm has a 50 day moving average price of $122.65 and a 200-day moving average price of $114.78. The stock has a market capitalization of $326.50 billion and a P/E ratio of 22.24.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, July 19th. The company reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of $1.68 by $0.06. The company earned $18.50 billion during the quarter, compared to the consensus estimate of $17.98 billion. On average, analysts anticipate that Johnson & Johnson will post $6.69 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 19th. Investors of record on Friday, August 5th were issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 0.97%.

In related news, CAO Ronald A. Kapusta sold 2,935 shares of the company’s stock in a transaction dated Friday, July 22nd. The stock was sold at an average price of $125.01, for a total value of $366,904.35. Following the completion of the sale, the chief accounting officer now owns 28,660 shares in the company, valued at $3,582,786.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Dominic J. Caruso sold 41,146 shares of the company’s stock in a transaction dated Tuesday, July 26th. The shares were sold at an average price of $125.01, for a total value of $5,143,661.46. Following the completion of the sale, the vice president now owns 157,819 shares of the company’s stock, valued at approximately $19,728,953.19. The disclosure for this sale can be found here.

A number of large investors recently added to or reduced their stakes in JNJ. CG Asset Management LLC increased its stake in Johnson & Johnson by 0.3% in the fourth quarter. CG Asset Management LLC now owns 55,737 shares of the company’s stock worth $5,725,000 after buying an additional 181 shares in the last quarter. Spectrum Advisory Services Inc. increased its stake in Johnson & Johnson by 0.7% in the fourth quarter. Spectrum Advisory Services Inc. now owns 32,603 shares of the company’s stock worth $3,349,000 after buying an additional 234 shares in the last quarter. Holderness Investments Co. increased its stake in Johnson & Johnson by 2.1% in the fourth quarter. Holderness Investments Co. now owns 14,942 shares of the company’s stock worth $1,535,000 after buying an additional 302 shares in the last quarter. Bruni J V & Co. Co. increased its stake in Johnson & Johnson by 0.9% in the fourth quarter. Bruni J V & Co. Co. now owns 39,669 shares of the company’s stock worth $4,075,000 after buying an additional 344 shares in the last quarter. Finally, Marco Investment Management LLC increased its stake in Johnson & Johnson by 2.3% in the fourth quarter. Marco Investment Management LLC now owns 48,052 shares of the company’s stock worth $4,936,000 after buying an additional 1,100 shares in the last quarter.

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company’s segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women’s health and wound care markets.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.